BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A, Frauendorfer K; European Group for Blood and Marrow Transplantation EBMT. The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant 2011;46:485-501. [PMID: 21358689 DOI: 10.1038/bmt.2011.11] [Cited by in Crossref: 112] [Cited by in F6Publishing: 102] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Gratwohl A, Baldomero H, Gratwohl M, Aljurf M, Bouzas LF, Horowitz M, Kodera Y, Lipton J, Iida M, Pasquini MC, Passweg J, Szer J, Madrigal A, Frauendorfer K, Niederwieser D; Worldwide Network of Blood and Marrow Transplantation (WBMT). Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica 2013;98:1282-90. [PMID: 23508009 DOI: 10.3324/haematol.2012.076349] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 9.1] [Reference Citation Analysis]
2 Hamilton BK, Copelan EA. Concise Review: The Role of Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia. STEM CELLS 2012;30:1581-6. [DOI: 10.1002/stem.1140] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
3 Lown RN, Shaw BE. Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision. Bone Marrow Transplant 2013;48:210-9. [DOI: 10.1038/bmt.2012.54] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
4 Khandelwal P, Millard HR, Thiel E, Abdel-Azim H, Abraham AA, Auletta JJ, Boulad F, Brown VI, Camitta BM, Chan KW, Chaudhury S, Cowan MJ, Angel-Diaz M, Gadalla SM, Gale RP, Hale G, Kasow KA, Keating AK, Kitko CL, MacMillan ML, Olsson RF, Page KM, Seber A, Smith AR, Warwick AB, Wirk B, Mehta PA. Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report. Biol Blood Marrow Transplant 2017;23:1342-9. [PMID: 28450183 DOI: 10.1016/j.bbmt.2017.04.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
5 Billen A, Madrigal JA, Shaw BE. A review of the haematopoietic stem cell donation experience: is there room for improvement? Bone Marrow Transplant 2014;49:729-36. [DOI: 10.1038/bmt.2013.227] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
6 Porter JB, de Witte T, Cappellini MD, Gattermann N. New insights into transfusion-related iron toxicity: Implications for the oncologist. Crit Rev Oncol Hematol 2016;99:261-71. [PMID: 26806144 DOI: 10.1016/j.critrevonc.2015.11.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
7 Karakukcu M, Unal E. Stem cell mobilization and collection from pediatric patients and healthy children. Transfus Apher Sci 2015;53:17-22. [PMID: 26116046 DOI: 10.1016/j.transci.2015.05.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dierselhuis MP, Blokland EC, Pool J, Schrama E, Scherjon SA, Goulmy E. Transmaternal cell flow leads to antigen-experienced cord blood. Blood 2012;120:505-10. [PMID: 22627770 DOI: 10.1182/blood-2012-02-410571] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
9 Salazar-Riojas R, García-Lozano JA, Valdés-Galván M, Martínez-González O, Cantú-Rodríguez OG, González-Llano O, Gómez-De León A, Jaime-Pérez JC, Gómez-Almaguer D, Gutiérrez-Aguirre CH. Effective collection of peripheral blood stem cells in children weighing 20 kilogram or less in a single large-volume apheresis procedure. J Clin Apher 2015;30:281-7. [PMID: 25557252 DOI: 10.1002/jca.21375] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
10 Smagur A, Mitrus I, Ciomber A, Panczyniak K, Fidyk W, Sadus-wojciechowska M, Holowiecki J, Giebel S. Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation. Vox Sang 2015;108:417-24. [DOI: 10.1111/vox.12238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
11 Lemos NE, Farias MG, Kubaski F, Scotti L, Onsten TGH, Brondani LA, Wagner SC, Sekine L. Quantification of peripheral blood CD34+ cells prior to stem cell harvesting by leukapheresis: a single center experience. Hematol Transfus Cell Ther 2018;40:213-8. [PMID: 30128429 DOI: 10.1016/j.htct.2018.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kuwatsuka Y. Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries. Int J Hematol 2016;103:20-4. [DOI: 10.1007/s12185-015-1896-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
13 Ali N, Adil SN, Shaikh MU, Moosajee M, Masood N. Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011. Exp Hematol Oncol 2012;1:13. [PMID: 23210643 DOI: 10.1186/2162-3619-1-13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
14 Holbro A, Abinun M, Daikeler T. Management of autoimmune diseases after haematopoietic stem cell transplantation. Br J Haematol 2012;157:281-90. [PMID: 22360687 DOI: 10.1111/j.1365-2141.2012.09070.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
15 de Faveri GN, Schwabe R, Bart T. Swiss Blood Stem Cells: More than Just a Registry. Transfus Med Hemother 2011;38:300-7. [PMID: 22670119 DOI: 10.1159/000331493] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Bensinger WI. Allogeneic transplantation: peripheral blood vs. bone marrow. Curr Opin Oncol 2012;24:191-6. [PMID: 22185938 DOI: 10.1097/CCO.0b013e32834f5c27] [Cited by in Crossref: 41] [Cited by in F6Publishing: 12] [Article Influence: 4.1] [Reference Citation Analysis]
17 Kanold J, Paillard C, Tchirkov A, Lang P, Kelly A, Halle P, Isfan F, Merlin E, Marabelle A, Rochette E, Deméocq F. NK Cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT. Pediatr Blood Cancer 2012;59:739-42. [DOI: 10.1002/pbc.24030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
18 Martino M, Fedele R, Massara E, Recchia AG, Irrera G, Morabito F. Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear? Expert Opinion on Biological Therapy 2012;12:609-21. [DOI: 10.1517/14712598.2012.674937] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
19 Paillard C, Rochette E, Lutz P, Bertrand Y, Michel G, Bordigoni P, Dalle JH, Rohrlich P, Vannier JP, Perel Y, Plantaz D, Leverger G, Sirvent A, Dore E, Isfan F, Merlin E, Pereira B, Halle P, Rabiau N, Kanold J, Deméocq F. Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Bone Marrow Transplant 2013;48:1401-8. [PMID: 23749103 DOI: 10.1038/bmt.2013.82] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
20 Messer M, Steinzen A, Vervölgyi E, Lerch C, Richter B, Dreger P, Herrmann-Frank A. Unrelated and alternative donor allogeneic stem cell transplant in patients with relapsed or refractory Hodgkin lymphoma: a systematic review. Leuk Lymphoma 2014;55:296-306. [PMID: 23656201 DOI: 10.3109/10428194.2013.802780] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
21 Yu J, Lal L, Anderson A, Ducharme M, Parasuraman S, Weisdorf D. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation. Support Care Cancer 2020;28:5491-9. [DOI: 10.1007/s00520-020-05382-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hefner J, Kapp M, Drebinger K, Dannenmann A, Einsele H, Grigoleit GU, Faller H, Csef H, Mielke S. High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age. Bone Marrow Transplant. 2014;49:581-584. [PMID: 24442247 DOI: 10.1038/bmt.2013.228] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
23 Gerull S, Stern M, Ben Aissa A, Manz MG, Schanz U, Stussi G, Chalandon Y, Passweg J, Mohty B. Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT. Bone Marrow Transplant 2013;48:408-13. [DOI: 10.1038/bmt.2012.167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Hamidieh AA, Behfar M, Babaki AES, Jalali A, Hosseini A, Jahani M, Alimoghaddam K, Ghavamzadeh A. Hematopoietic SCT in Iranian children 1991–2012. Bone Marrow Transplant 2015;50:517-22. [DOI: 10.1038/bmt.2014.299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Horne B, Gilleece M, Jackson G, Snowden J, Liebersbach S, Velikova G, Wright P. Psychosocial supportive care services for haematopoietic stem cell transplant patients; a service evaluation of three UK transplant centres: HSCT psychosocial supportive care service evaluation. Eur J Cancer Care (Engl) 2014;23:349-62. [DOI: 10.1111/ecc.12160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
26 Caunday O, Agulles O, McGrath E, Empereur F, Stoltz JF, Chabannon C. Implementation of JACIE accreditation results in the establishment of new indicators that unevenly monitor processes contributing to the delivery of hematopoietic SCT. Bone Marrow Transplant 2013;48:604-9. [PMID: 23528642 DOI: 10.1038/bmt.2012.181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Coluccia P, Crovetti G, Del Fante C, Dallavalle FM, Laszlò D, Ferremi P, Marenchino D, Santoleri L, De Filippo C, Mattana F, Mariani L, Perseghin P, Ravagnani F. Screening of related donors and peripheral blood stem cell collection practices at different Italian apheresis centres. Blood Transfus 2012;10:440-7. [PMID: 22871823 DOI: 10.2450/2012.0140-11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
28 Maschan AA, Balashov DN, Kurnikova EE, Trakhtman PE, Boyakova EV, Skorobogatova EV, Novichkova GA, Maschan MA. Efficacy of plerixafor in children with malignant tumors failing to mobilize a sufficient number of hematopoietic progenitors with G-CSF. Bone Marrow Transplant 2015;50:1089-91. [DOI: 10.1038/bmt.2015.71] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
29 Morris C, de Wreede L, Scholten M, Brand R, van Biezen A, Sureda A, Dickmeiss E, Trneny M, Apperley J, Chiusolo P, van Imhoff GW, Lenhoff S, Martinelli G, Hentrich M, Pabst T, Onida F, Quinn M, Kroger N, de Witte T, Ruutu T; Chronic Malignancies and Lymphoma Working Parties of the EBMT. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide: DMSO Side Effects in Autologous Transplantation. Transfusion 2014;54:2514-22. [DOI: 10.1111/trf.12759] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 6.5] [Reference Citation Analysis]
30 Innes AJ, Beattie R, Sergeant R, Damaj G, Foroni L, Marin D, Kanfer E, Mielke S, Milojkovic D, Macdonald D, Pavlu J, Rahemtulla A, Roberts I, Slade D, Bray E, Goldman J, Apperley J, Szydlo R, Dazzi F, Rezvani K. Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT. Bone Marrow Transplant 2013;48:1324-8. [DOI: 10.1038/bmt.2013.69] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
31 Bunse CE, Tischer S, Lahrberg J, Oelke M, Figueiredo C, Blasczyk R, Eiz-Vesper B. Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements. Clin Exp Immunol 2016;185:107-18. [PMID: 26990855 DOI: 10.1111/cei.12794] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
32 Costa Pereira W, Alsuhaibani O, Elyamany G, Al Abdulaaly A. A novel approach for the enumeration of peripheral blood stem cells suitable for transplantation. J Transplant 2014;2014:473503. [PMID: 25165572 DOI: 10.1155/2014/473503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Varmavuo V, Rimpiläinen J, Kuitunen H, Nihtinen A, Vasala K, Mikkola M, Kutila A, Lehtonen P, Kuittinen T, Mäntymaa P, Nousiainen T, Kuittinen O, Jantunen E. Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients: Outcome after Plerixafor Treatment. Transfusion 2014;54:1243-50. [DOI: 10.1111/trf.12434] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
34 Labopin M, Gorin N, Polge E, Socié G, Gurman G, Gluckman E, Jindra P, Poiré X, Schäfer-eckart K, Ruutu T, Milone G, Arcese W, Mohty M, Rocha V; on behalf of the Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow transplantation (EBMT). A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. Bone Marrow Transplant 2014;49:376-81. [DOI: 10.1038/bmt.2013.178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
35 Benakli M, Ahmed Nacer R, Mehdid F, Belhadj R, Rahmoune N, Baazizi M, Ait Ouali D, Harieche F, Hamladji R. Peripheral Blood Stem Cell Mobilization and Collection in Pediatric Healthy Sibling Donors Weighing 20 Kilograms or Less; Algerian Experience. Transfusion and Apheresis Science 2020;59:102987. [DOI: 10.1016/j.transci.2020.102987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Cesaro S, Tintori V, Nesi F, Schiavello E, Calore E, Dallorso S, Migliavacca M, Capolsini I, Desantis R, Caselli D, Fagioli F, Luksch R, Panizzolo I, Tridello G, Prete A. A prospective study on the efficacy of mobilization of autologous peripheral stem cells in pediatric oncohematology patients: Pediatric Stem Cell Mobilization. Transfusion 2013;53:1501-9. [DOI: 10.1111/j.1537-2995.2012.03911.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
37 Finke J, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR, Volin L, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Bertz H, Grishina O, Socié G; ATG-Fresenius Trial Group. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial. Biol Blood Marrow Transplant 2012;18:1716-26. [PMID: 22713691 DOI: 10.1016/j.bbmt.2012.06.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
38 Christopeit M, Kuss O, Finke J, Bacher U, Beelen DW, Bornhäuser M, Schwerdtfeger R, Bethge WA, Basara N, Gramatzki M, Tischer J, Kolb HJ, Uharek L, Meyer RG, Bunjes D, Scheid C, Martin H, Niederwieser D, Kröger N, Bertz H, Schrezenmeier H, Schmid C. Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change. J Clin Oncol 2013;31:3259-71. [PMID: 23918951 DOI: 10.1200/JCO.2012.44.7961] [Cited by in Crossref: 89] [Cited by in F6Publishing: 33] [Article Influence: 9.9] [Reference Citation Analysis]
39 Phillips EH, Hodson A, Hermine O, Bazarbachi A, Cwynarski K. Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant? Bone Marrow Transplant 2016;51:1549-55. [PMID: 27618683 DOI: 10.1038/bmt.2016.154] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
40 Zhou M, Zheng Y, Ma S, Zhou D, Li L, Zhu J, Zhu L, Yang X, Luo Y, Huang H, Ye X, Xie W. Clinical Observation on Hemogram Variation of Allogeneic Donors from Chinese Population for Peripheral Hematopoietic Stem Cell Collection. Stem Cells and Development 2016;25:798-802. [DOI: 10.1089/scd.2016.0017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Smagur A, Mitrus I, Giebel S, Sadus-wojciechowska M, Najda J, Kruzel T, Czerw T, Gliwinska J, Prokop M, Glowala-kosinska M, Chwieduk A, Holowiecki J. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells: Effect of DMSO concentrations on cryopreserved HSPCs. Vox Sanguinis 2013;104:240-7. [DOI: 10.1111/j.1423-0410.2012.01657.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
42 Shin SH, Lee SE, Lee JW. Recent advances in treatment of aplastic anemia. Korean J Intern Med 2014;29:713-26. [PMID: 25378968 DOI: 10.3904/kjim.2014.29.6.713] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
43 Wittmann T, Horowitz N, Benyamini N, Henig I, Zuckerman T, Rowe JM, Kra-Oz Z, Szwarcwort Cohen M, Oren I, Avivi I. JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications. Bone Marrow Transplant 2015;50:984-91. [PMID: 25867649 DOI: 10.1038/bmt.2015.68] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
44 Özkurt ZN, Batmaz L, Yeğin ZA, İlhan Ç. Factors affecting hematopoietic stem cell mobilization and apheresis in allogeneic donors: The role of iron status. Transfus Apher Sci 2017;56:470-3. [PMID: 28647301 DOI: 10.1016/j.transci.2017.05.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
45 Wu S, Zhang C, Zhang X, Xu Y, Deng T. Is peripheral blood or bone marrow a better source of stem cells for transplantation in cases of HLA-matched unrelated donors? A meta-analysis. Critical Reviews in Oncology/Hematology 2015;96:20-33. [DOI: 10.1016/j.critrevonc.2015.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
46 Khalil MMI, Lipton JH, Atenafu EG, Gupta V, Kim DD, Kuruvilla J, Viswabandya A, Messner HA, Michelis FV. Impact of comorbidities constituting the hematopoietic cell transplant (HCT)-comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia. Eur J Haematol 2018;100:198-205. [DOI: 10.1111/ejh.13000] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
47 Brunet S, Labopin M, Esteve J, Cornelissen J, Socié G, Iori AP, Verdonck LF, Volin L, Gratwohl A, Sierra J. Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis. J Clin Oncol. 2012;30:735-741. [PMID: 22291086 DOI: 10.1200/jco.2011.36.9868] [Cited by in Crossref: 173] [Cited by in F6Publishing: 81] [Article Influence: 17.3] [Reference Citation Analysis]
48 Kuster S, Stampf S, Gerber B, Baettig V, Weisser M, Gerull S, Medinger M, Passweg J, Schanz U, Garzoni C, Berger C, Chalandon Y, Mueller NJ, van Delden C, Neofytos D, Khanna N; Swiss Transplant Cohort Study. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study. Transpl Infect Dis 2018;20:e12981. [PMID: 30144374 DOI: 10.1111/tid.12981] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
49 Mohamed SYA, Fadhil I, Hamladji R, Ali Hamidieh A, Fahmy O, Ladeb S, Alimoghaddam K, Elhaddad A, Ahmed Nacer R, Alsharif F, Rasheed W, Jahani M, Mousavi SA, Alseraihy A, Abdel-rahman F, Al Jefri A, Hussein AA, Alabdulaaly A, Ibrahim A, Bekadja M, Abboud M, Ahmed P, Dennison D, Bakr M, Benchekroun S, Hussain F, Othman TB, Aljurf M, Ghavamzadeh A. Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: Report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group. Hematology/Oncology and Stem Cell Therapy 2011;4:81-93. [DOI: 10.5144/1658-3876.2011.81] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
50 Martino M, Montanari M, Bruno B, Console G, Irrera G, Messina G, Offidani M, Scortechini I, Moscato T, Fedele R, Milone G, Castagna L, Olivieri A. Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program. Expert Opinion on Biological Therapy 2012;12:1449-62. [DOI: 10.1517/14712598.2012.707185] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
51 Suárez-González J, Martínez-Laperche C, Kwon M, Balsalobre P, Carbonell D, Chicano M, Rodríguez-Macías G, Serrano D, Gayoso J, Díez-Martín JL, Buño I. Donor Cell-Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review. Biol Blood Marrow Transplant 2018;24:1505-13. [PMID: 29410295 DOI: 10.1016/j.bbmt.2018.01.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
52 Giebel S, Kruzel T, Czerw T, Sadus-wojciechowska M, Najda J, Chmielowska E, Grosicki S, Jurczyszyn A, Pasiarski M, Nowara E, Glowala-kosinka M, Chwieduk A, Mitrus I, Smagur A, Holowiecki J. Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers. Bone Marrow Transplant 2013;48:915-21. [DOI: 10.1038/bmt.2012.269] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
53 Zheng Y, Zhou M, Xie W, Zhou D, Li L, Zhu J, Zhu L, Yang X, Luo Y, Huang H, Ye X. [Short-term effects of hemogram in healthy donors after peripheral blood stem cell collection]. Zhonghua Xue Ye Xue Za Zhi 2015;36:1011-5. [PMID: 26759103 DOI: 10.3760/cma.j.issn.0253-2727.2015.12.007] [Reference Citation Analysis]
54 Halagan M, Manor S, Shriki N, Yaniv I, Zisser B, Madbouly A, Maiers M, Stein J. East Meets West-Impact of Ethnicity on Donor Match Rates in the Ezer Mizion Bone Marrow Donor Registry. Biol Blood Marrow Transplant 2017;23:1381-6. [PMID: 28396163 DOI: 10.1016/j.bbmt.2017.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
55 Pierelli L, Perseghin P, Marchetti M, Accorsi P, Fanin R, Messina C, Olivieri A, Risso M, Salvaneschi L, Bosi A; for Società Italiana Di Emaferesi and Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO). Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process: PBPC MOBILIZATION AND COLLECTION. Transfusion 2012;52:893-905. [DOI: 10.1111/j.1537-2995.2011.03385.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
56 Toffalori C, Cavattoni I, Deola S, Mastaglio S, Giglio F, Mazzi B, Assanelli A, Peccatori J, Bordignon C, Bonini C, Cortelazzo S, Ciceri F, Fleischhauer K, Vago L. Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT. Blood 2012;119:4813-5. [PMID: 22596173 DOI: 10.1182/blood-2012-02-411686] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
57 O'Meara A, Halter J, Heim D, Gerull S, Bucher C, Passweg J, Buser A, Stern M. Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBI. Biol Blood Marrow Transplant 2013;19:82-6. [PMID: 22897965 DOI: 10.1016/j.bbmt.2012.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
58 Even-or E, Grunspan A, Swerdlow Y, Kodman Y, Yahel A, Katz J, Krauss A, Yaniv I, Stein J. Peripheral blood stem-cell harvest using percutaneous arterial lines in children. Pediatr Blood Cancer 2013;60:946-8. [DOI: 10.1002/pbc.24369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
59 Nivison-Smith I, Bardy P, Dodds AJ, Ma DDF, Aarons D, Tran S, Wilcox L, Szer J. A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013. Biol Blood Marrow Transplant 2016;22:284-91. [PMID: 26385524 DOI: 10.1016/j.bbmt.2015.09.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
60 Yu X, Liu L, Xie Z, Dong C, Zhao L, Zhang J, Gu J, Zhu HH. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis. Crit Rev Oncol Hematol 2019;133:120-8. [PMID: 30661648 DOI: 10.1016/j.critrevonc.2018.05.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
61 Auberger J, Clausen J, Kircher B, Kropshofer G, Lindner B, Nachbaur D. Allogeneic bone marrow vs. peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients: Retrospective analysis of BMT vs. PBSCT. European Journal of Haematology 2011;87:531-8. [DOI: 10.1111/j.1600-0609.2011.01692.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
62 Takeshima T, Ueno H, Yamamoto M, Usui K, Mori K, Asai T, Yasuda K, Kuroda S, Kawahara T, Miyoshi Y, Uemura H, Yumura Y. Sperm cryopreservation for fertility preservation in male patients with cancer at a single-center in Japan. Global Reproductive Health 2019;4:e34-e34. [DOI: 10.1097/grh.0000000000000034] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Mielcarek M, Storer B, Martin PJ, Forman SJ, Negrin RS, Flowers ME, Inamoto Y, Chauncey TR, Storb R, Appelbaum FR. Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow. Blood. 2012;119:2675-2678. [PMID: 22308289 DOI: 10.1182/blood-2011-12-396275] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
64 Schwartzberg LS, Jacobs P, Matsouka P, Azevedo W, Pinto A. The role of second-generation 5-HT3 receptor antagonists in managing chemotherapy-induced nausea and vomiting in hematological malignancies. Critical Reviews in Oncology/Hematology 2012;83:59-70. [DOI: 10.1016/j.critrevonc.2011.09.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
65 Tekgündüz E, Altuntaş F, Şıvgın S, Akı ŞZ, Dönmez A, Topçuoğlu P, Yıldırım R, Baysal NA, Ayyıldız E, Yüksel MK, Sarı İ, Tombuloğlu M, Ünal A, İlhan O. Plerixafor use in patients with previous mobilization failure: A multicenter experience. Transfusion and Apheresis Science 2012;47:77-80. [DOI: 10.1016/j.transci.2012.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
66 Alvarez P, Carrillo E, Vélez C, Hita-Contreras F, Martínez-Amat A, Rodríguez-Serrano F, Boulaiz H, Ortiz R, Melguizo C, Prados J. Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing. Biomed Res Int. 2013;2013:312656. [PMID: 23844360 DOI: 10.1155/2013/312656] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
67 Geißler RG, Franz D, Buddendick H, Krakowitzky P, Bunzemeier H, Roeder N, Van Aken H, Kessler T, Berdel W, Sibrowski W, Schlenke P. Retrospective Analysis of the Blood Component Utilization in a University Hospital of Maximum Medical Care. Transfus Med Hemother 2012;39:129-38. [PMID: 22670131 DOI: 10.1159/000337956] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
68 Ringdén O, Labopin M, Beelen DW, Volin L, Ehninger G, Finke J, Greinix HT, Kyrcz-Krzemien S, Bunjes D, Brinch L, Niederwieser D, Arnold R, Mohty M, Rocha V; Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT). Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients. J Intern Med 2012;272:472-83. [PMID: 22519980 DOI: 10.1111/j.1365-2796.2012.02547.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
69 Adhikari J, Sharma P, Bhatt VR. Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood? Future Oncol 2016;12:1823-32. [PMID: 27168462 DOI: 10.2217/fon-2016-0106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
70 Nagler A, Labopin M, Shimoni A, Mufti GJ, Cornelissen JJ, Blaise D, Janssen JJ, Milpied N, Vindelov L, Petersen E, Gribben J, Bacigalupo A, Malm C, Niederwieser D, Socié GJ, Arnold R, Brown P, Goker H, Rocha V, Mohty M; ALWP-EBMT. Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT. Eur J Haematol 2012;89:206-13. [PMID: 22650267 DOI: 10.1111/j.1600-0609.2012.01811.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
71 Chabannon C, Bijou F, Miclea JM, Milpied N, Grouin JM, Mohty M. A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the "on-demand" scheme of administration at French autologous hematopoietic stem cell transplant programs. Transfusion 2015;55:2149-57. [PMID: 25968564 DOI: 10.1111/trf.13141] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
72 Worel N. ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation. Transfus Med Hemother 2016;43:3-12. [PMID: 27022317 DOI: 10.1159/000441507] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 6.1] [Reference Citation Analysis]
73 Styczyński J, Kałwak K, Ussowicz M, Owoc-lempach J, Chybicka A, Pieczonka A, Dębski R, Krenska A, Drabko K, Kowalczyk J, Boruczkowski D, Wysocki M, Wachowiak J. Przeszczepianie krwi pępowinowej w polskich ośrodkach pediatrycznych: raport Polskiej Pediatrycznej Grupy ds. Transplantacji Komórek Krwiotwórczych. Acta Haematologica Polonica 2012;43:265-70. [DOI: 10.1016/s0001-5814(12)34003-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Yiğenoğlu TN, Başcı S, Bakırtaş M, Ulu BU, Kılınç A, Şahin D, Darçın T, Yıldız J, Merdin A, Baysal NA, İskender D, Çakar MK, Dal MS, Hacıbekiroğlu T, Altuntaş F. The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors. Transfus Apher Sci 2020;59:102726. [PMID: 32008954 DOI: 10.1016/j.transci.2020.102726] [Reference Citation Analysis]
75 Lysák D, Merglová L, Navrátilová J, Svoboda T, Jindra P, Koza V. CD34⁺ cell content in unrelated allogeneic peripheral blood stem cell grafts transported internationally. Does the inter-laboratory variability affect comparability of graft quality data? Transfus Apher Sci 2012;47:179-84. [PMID: 22842107 DOI: 10.1016/j.transci.2012.06.022] [Reference Citation Analysis]
76 Varmavuo V, Mäntymaa P, Silvennoinen R, Nousiainen T, Kuittinen T, Jantunen E. CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients. Transfusion 2013;53:1024-32. [PMID: 22897584 DOI: 10.1111/j.1537-2995.2012.03848.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
77 Schmid C, Labopin M, Nagler A, Niederwieser D, Castagna L, Tabrizi R, Stadler M, Kuball J, Cornelissen J, Vorlicek J, Socié G, Falda M, Vindeløv L, Ljungman P, Jackson G, Kröger N, Rank A, Polge E, Rocha V, Mohty M; Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation. Blood 2012;119:1599-606. [PMID: 22167752 DOI: 10.1182/blood-2011-08-375840] [Cited by in Crossref: 170] [Cited by in F6Publishing: 164] [Article Influence: 15.5] [Reference Citation Analysis]
78 Zhou P, Liu P, Zhou SY, He XH, Han XH, Qin Y, Yang S, Zhang CG, Gui L, Yao JR, Zhao LY, Zhang SX, Sun Y, Shi YK. Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas. Chin Med J (Engl) 2015;128:2498-504. [PMID: 26365969 DOI: 10.4103/0366-6999.164936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
79 Seo BY, Choi HW, Kang MG, Cho D, Kee SJ, Kim SH, Shin JH, Suh SP, Ryang DW, Shin MG. Constitutional chromosomal abnormality identified in a sibling donor after bone marrow stem cell transplantation in a pediatric patient with acute megakaryoblastic leukemia. Ann Lab Med 2015;35:162-4. [PMID: 25553302 DOI: 10.3343/alm.2015.35.1.162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Lemos NE, Farias MG, Kubaski F, Scotti L, Onsten TGH, Brondani LDA, Wagner SC, Sekine L. WITHDRAWN: Quantification of peripheral blood CD34+ cells prior to stem cell harvesting by leukapheresis: a single center experience. Revista Brasileira de Hematologia e Hemoterapia 2017. [DOI: 10.1016/j.bjhh.2017.10.002] [Reference Citation Analysis]
81 Basak GW, de Wreede LC, van Biezen A, Wiktor-jedrzejczak W, Halaburda K, Schmid C, Schaap N, Dazzi F, von dem Borne PA, Petersen E, Beelen D, Abayomi A, Volin L, Buzyn A, Gurman G, Bunjes D, Guglielmi C, Olavarria E, de Witte T; Chronic Malignancies Working Party EBMT. Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation. Bone Marrow Transplant 2013;48:837-42. [DOI: 10.1038/bmt.2012.234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
82 Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A; Late Effects Working Party of the EBMT. Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 2013;98:339-45. [PMID: 22929982 DOI: 10.3324/haematol.2012.071944] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
83 Rinaldi C, Savignano C, Pasca S, Sperotto A, Patriarca F, Isola M, Fanin R, De Angelis V. Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors. Transfusion 2012;52:2387-94. [PMID: 22452363 DOI: 10.1111/j.1537-2995.2012.03619.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
84 Bunse CE, Borchers S, Varanasi PR, Tischer S, Figueiredo C, Immenschuh S, Kalinke U, Köhl U, Goudeva L, Maecker-Kolhoff B, Ganser A, Blasczyk R, Weissinger EM, Eiz-Vesper B. Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor. PLoS One 2013;8:e77925. [PMID: 24324576 DOI: 10.1371/journal.pone.0077925] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
85 Engel N, Rank A. Epigenomics in hematopoietic transplantation: novel treatment strategies. Epigenomics 2011;3:611-23. [DOI: 10.2217/epi.11.80] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
86 Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database Syst Rev 2014;:CD010189. [PMID: 24748537 DOI: 10.1002/14651858.CD010189.pub2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
87 Bertani G, Santoleri L, Martino M, Fedele R, Moscato T, Marenco P, Grillo G, Zucchetti E, Lotesoriere I, Lando G, Cesana C, Cairoli R, Rossini S. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study: Identification of HPC Donor Characteristics. Transfusion 2014;54:2028-33. [DOI: 10.1111/trf.12612] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
88 Silla LM, Dulley F, Saboya R, Paton E, Kerbauy F, Arantes Ade M, Hamerschlak N. Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines. Rev Bras Hematol Hemoter 2013;35:56-61. [PMID: 23580886 DOI: 10.5581/1516-8484.20130016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
89 Estcourt LJ. Why has demand for platelet components increased? A review: Why has demand for platelet components increased? Transfusion Med 2014;24:260-8. [DOI: 10.1111/tme.12155] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
90 Passera R, Pollichieni S, Brunello L, Patriarca F, Bonifazi F, Montefusco V, Falda M, Montanari M, Guidi S, Giaccone L, Mordini N, Carella AM, Bavaro P, Milone G, Benedetti F, Ciceri F, Scimè R, Benedetti E, Castagna L, Festuccia M, Rambaldi A, Bacigalupo A, Corradini P, Bosi A, Boccadoro M, Bandini G, Fanin R, Bruno B. Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry. Biol Blood Marrow Transplant 2013;19:940-8. [PMID: 23538113 DOI: 10.1016/j.bbmt.2013.03.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
91 Zhu Y, Gao Q, Du J, Hu J, Liu X, Zhang F. Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysis. Ann Hematol 2018;97:1519-26. [PMID: 29946906 DOI: 10.1007/s00277-018-3414-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
92 Blaise D, Castagna L. Do different conditioning regimens really make a difference? Hematology 2012;2012:237-45. [DOI: 10.1182/asheducation.v2012.1.237.3798315] [Cited by in Crossref: 22] [Article Influence: 2.2] [Reference Citation Analysis]
93 Martino M, Bottini A, Rosti G, Generali D, Secondino S, Barni S, Maisano R, Lanza F, Castagna L, Pedrazzoli P. Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients. Expert Opin Biol Ther 2012;12:1505-15. [PMID: 22946512 DOI: 10.1517/14712598.2012.721767] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
94 Tang F, Mo X, Zhang X, Wang Y, Yan C, Chen Y, Chen H, Han W, Chen Y, Wang F, Wang J, Sun Y, Zhang Y, Liu K, Huang X, Xu L. Influence of the degree of donor bone marrow hyperplasia on patient clinical outcomes after allogeneic hematopoietic stem cell transplantation. Sci China Life Sci 2020;63:138-47. [PMID: 31432375 DOI: 10.1007/s11427-018-9509-y] [Reference Citation Analysis]
95 Pessach I, Resnick I, Shimoni A, Nagler A. G-CSF-primed BM for allogeneic SCT: revisited. Bone Marrow Transplant 2015;50:892-8. [DOI: 10.1038/bmt.2015.25] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
96 Raj K, Pagliuca A, Bradstock K, Noriega V, Potter V, Streetly M, McLornan D, Kazmi M, Marsh J, Kwan J, Huang G, Getzendaner L, Lee S, Guthrie KA, Mufti GJ, O'Donnell P. Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning. Biol Blood Marrow Transplant 2014;20:890-5. [PMID: 24650678 DOI: 10.1016/j.bbmt.2014.03.003] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 12.3] [Reference Citation Analysis]
97 Chen J, Burns KM, Babic A, Carrum G, Kennedy M, Segura FJ, Garcia S, Potts S, Leveque C. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor. Transfusion 2014;54:203-10. [PMID: 23763340 DOI: 10.1111/trf.12238] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
98 Hussein AA, Hamidieh AA, Elhaddad A, Ramzi M, Othman TB, Hussain F, Dennison D, Ahmed P, Abboud M, Al-Ahmari A, Wahadneh A, Fathy J, Bekadja MA, Al-Kindi S, Benchekroun S, Ibrahim A, Behfar M, Samra M, Ladeb S, Adil S, El-Solh H, Ayas M, Aljurf M, Ghavamzadeh A, Al-Seraihy A; Pediatric Cancer Working Committee of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group. Bone Marrow Transplant 2017;52:120-5. [PMID: 27618684 DOI: 10.1038/bmt.2016.209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
99 Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso de Faveri G, Shaw BE, Schmidt AH, Fechter M, Madrigal A. Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant. 2013;48:220-225. [PMID: 22773129 DOI: 10.1038/bmt.2012.119] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
100 Suenaga F, Ueha S, Abe J, Kosugi-kanaya M, Wang Y, Yokoyama A, Shono Y, Shand FHW, Morishita Y, Kunisawa J, Sato S, Kiyono H, Matsushima K. Loss of Lymph Node Fibroblastic Reticular Cells and High Endothelial Cells Is Associated with Humoral Immunodeficiency in Mouse Graft-versus-Host Disease. J I 2014;194:398-406. [DOI: 10.4049/jimmunol.1401022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
101 Vago L, Oliveira G, Bondanza A, Noviello M, Soldati C, Ghio D, Brigida I, Greco R, Lupo Stanghellini MT, Peccatori J. T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation. Blood. 2012;120:1820-1830. [PMID: 22709689 DOI: 10.1182/blood-2012-01-405670] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
102 Thakkar D, Tiwari AK, Pabbi S, Kapoor R, Aggarwal G, Rastogi N, Yadav SP. Peripheral blood stem cell mobilization with pegylated granulocyte colony stimulating factor in children. Cancer Rep (Hoboken) 2021;:e1408. [PMID: 34245131 DOI: 10.1002/cnr2.1408] [Reference Citation Analysis]
103 Varmavuo V, Mäntymaa P, Nousiainen T, Valonen P, Kuittinen T, Jantunen E. Blood graft composition after plerixafor injection in patients with NHL. Eur J Haematol 2012;89:128-35. [PMID: 22536949 DOI: 10.1111/j.1600-0609.2012.01794.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
104 Toze CL, Dalal CB, Nevill TJ, Gillan TL, Abou Mourad YR, Barnett MJ, Broady RC, Forrest DL, Hogge DE, Nantel SH, Power MM, Song KW, Sutherland HJ, Smith CA, Narayanan S, Young SS, Connors JM, Shepherd JD. Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort. Br J Haematol 2012;158:174-85. [DOI: 10.1111/j.1365-2141.2012.09170.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
105 Kruzel T, Sadus-wojciechowska M, Najda J, Czerw T, Glowala-kosinska M, Holowiecki J, Giebel S. Very high efficacy of intermediate-dose cytarabine in combination with G-CSF as a second-line mobilization of hematopoietic stem cells. Int J Hematol 2012;96:287-9. [DOI: 10.1007/s12185-012-1135-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]